Historial de ingresos, beneficios y flujo de caja según los estados financieros oficiales.
Aflac Incorporated, a través de sus subsidiarias, ofrece productos complementarios de seguros de vida y de salud. Opera en dos segmentos, Aflac Japón y Aflac U.S. El segmento de Aflac Japón ofrece productos de seguros contra el cáncer, médicos, de enfermería, de vida entera y GIFT, así como productos de seguros WAYS y de dotación infantil y Tsumitasu en Japón. Su segmento Aflac U.S. ofrece productos de seguros contra accidentes, discapacidad, cáncer, enfermedades críticas, indemnización hospitalaria, dental, oftalmológica y de vida en los Estados Unidos.
Traducido automáticamente
Ver gráficos interactivos y estados completos → Modelo de valoración (DCF) →
| Cuenta de resultados | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos totales | $18.1B | $17.4B | $19.1B | $18.8B | $19.2B | $22.1B | $22.1B | $22.3B | $21.8B | $21.7B | $22.6B | $20.9B | $22.7B | $23.9B | $25.4B | $22.2B | $20.7B | $18.3B | $16.6B | $15.4B | $14.6B |
| Beneficio bruto | $9.8B | $6.8B | $6.8B | $18.8B | $19.2B | $22.1B | $22.1B | $22.3B | $21.8B | $21.7B | $22.6B | $20.9B | $22.7B | $23.9B | $25.4B | $22.2B | $20.7B | $18.2B | $16.6B | $15.4B | $14.6B |
| % de margen bruto | 53.9% | 38.9% | 35.6% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 99.6% | 100.0% | 100.0% | 100.0% |
| Ingresos operativos (EBIT) | $5.8B | $4.6B | $6.4B | $5.3B | $4.9B | $5.3B | $4.2B | $4.4B | $4.2B | $4.3B | $4.3B | $4.2B | $4.8B | $5.1B | $4.6B | $3.2B | $3.7B | $2.3B | $1.9B | $2.5B | $2.3B |
| % de margen operativo | 32.2% | 26.6% | 33.6% | 27.9% | 25.4% | 24.1% | 18.8% | 19.9% | 19.3% | 19.7% | 19.2% | 19.9% | 21.1% | 21.3% | 18.0% | 14.4% | 18.0% | 12.6% | 11.6% | 16.4% | 15.6% |
| Ingresos netos | $4.9B | $3.6B | $5.4B | $4.7B | $4.4B | $4.3B | $4.8B | $3.3B | $2.9B | $4.4B | $2.7B | $2.5B | $3.0B | $3.2B | $2.9B | $2.0B | $2.3B | $1.5B | $1.3B | $1.6B | $1.5B |
| % de margen neto | 26.9% | 20.9% | 28.5% | 24.7% | 23.1% | 19.6% | 21.6% | 14.8% | 13.4% | 20.2% | 11.8% | 12.1% | 13.0% | 13.2% | 11.3% | 8.9% | 11.3% | 8.2% | 7.6% | 10.6% | 10.2% |
| EBITDA | $6.9B | $5.5B | $6.4B | $5.3B | $4.9B | $6.5B | $5.4B | $4.4B | $4.2B | $4.3B | $4.3B | $4.2B | $4.8B | $5.1B | $4.6B | $3.2B | $3.7B | $2.3B | $2.0B | $2.5B | $2.3B |
| Beneficio por acción (EPS) | $9.28 | $6.85 | $9.63 | $7.78 | $6.93 | $6.39 | $6.67 | $4.43 | $3.77 | $5.48 | $3.21 | $2.92 | $3.25 | $3.38 | $3.05 | $2.09 | $2.48 | $1.60 | $1.31 | $1.65 | $1.48 |
| Acciones en circulación (M) | 506M | 532M | 565M | 599M | 638M | 677M | 716M | 746M | 775M | 798M | 828M | 866M | 908M | 935M | 939M | 939M | 946M | 938M | 958M | 988M | 1,004M |
Fuente: informes públicos de la empresa (SEC). Verifique en SEC EDGAR antes de confiar en cualquier cifra.
Balances, flujos de caja, datos trimestrales y ratios completos en el visor interactivo de AFL. /companies/us/AFL
La información de este sitio es solo educativa e informativa; no constituye asesoramiento de inversión. No se publican precios objetivo ni recomendaciones.
About TickerBase · Data methodology & sources · Privacy · Terms